What is the likelihood of future infertility in a 22‑year‑old woman with polycystic ovary syndrome who is taking spironolactone and a combined estrogen‑progestin oral contraceptive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likelihood of Future Infertility in PCOS Patients on Spironolactone and Birth Control

Your current treatment with spironolactone and birth control pills does not cause permanent infertility, and most women with PCOS can conceive successfully after discontinuing these medications. 1, 2

Understanding PCOS and Fertility

PCOS itself—not your medications—is the primary fertility consideration. PCOS is a leading cause of infertility, affecting 7-15% of reproductive-age women, but this does not mean you will be infertile. 3

Key Facts About PCOS and Conception:

  • Approximately 20-25% of women with PCOS ovulate spontaneously, meaning natural conception is possible even without treatment. 2

  • With appropriate fertility treatment, approximately 80% of PCOS patients achieve ovulation and about half conceive using first-line medications like clomiphene citrate. 4

  • Your current medications are fully reversible—both combined oral contraceptives and spironolactone do not cause permanent changes to ovarian function. 1, 2

Impact of Your Current Medications

Combined Oral Contraceptives (Birth Control Pills):

  • COCs temporarily suppress ovulation but do not damage ovarian reserve or cause lasting infertility. Once discontinued, ovarian function typically returns within 1-3 months. 1, 2

  • Long-term COC use (>3 years) actually provides significant protection against ovarian cancer, which may indirectly preserve fertility by preventing ovarian pathology. 1

  • COCs are protecting your endometrium from the hyperplasia risk associated with irregular cycles in PCOS, which is important for future pregnancy success. 2, 4

Spironolactone:

  • Spironolactone must be discontinued before attempting pregnancy due to teratogenic risk (potential to feminize male fetuses), but it causes no permanent fertility impairment. 5, 4

  • The medication works by blocking androgen receptors and does not damage ovarian tissue or egg quality. 4

Your Fertility Outlook When Ready to Conceive

Step 1: Discontinue Medications (3-6 Months Before Attempting Pregnancy)

  • Stop spironolactone immediately when you begin trying to conceive, as it is pregnancy category C with teratogenic potential. 5, 4

  • Discontinue birth control pills to allow resumption of natural ovulation; most women see cycle return within 1-3 months. 1

Step 2: Optimize Metabolic Health

  • Achieve 5-10% weight loss through lifestyle modification if you are overweight, as this significantly improves ovulation rates and pregnancy outcomes in PCOS. 4

  • Target an energy deficit of 500-750 kcal/day with at least 150 minutes/week of moderate-intensity exercise to enhance insulin sensitivity and reproductive function. 4

Step 3: First-Line Fertility Treatment if Needed

  • Clomiphene citrate is the first-line medication for ovulation induction in PCOS, with an 80% ovulation rate and 50% conception rate. 4, 3

  • Metformin may be added if you have documented insulin resistance or glucose intolerance, though it is not recommended solely for fertility in metabolically healthy patients. 4, 3

Step 4: Second-Line Options if First-Line Fails

  • Low-dose gonadotropin therapy is the next step if clomiphene fails, with lower risk of ovarian hyperstimulation compared to higher doses. 4

  • Laparoscopic ovarian drilling is a surgical option that can restore ovulation when medical treatment is unsuccessful. 3

  • In vitro fertilization (IVF) or in vitro maturation (IVM) remain third-line options with excellent success rates in PCOS patients. 3

Important Protective Factors in Your Case

You Are Not the "Typical Physical Type":

  • Lean or normal-weight PCOS patients often have better fertility outcomes compared to obese PCOS patients, as they typically have less severe insulin resistance. 4

  • Your metabolic profile likely carries lower cardiovascular and diabetes risk, which translates to better pregnancy outcomes. 4

You Are Young (22 Years Old):

  • Age is the single most important fertility factor, and at 22 you have excellent ovarian reserve and egg quality regardless of PCOS status. 4

  • You have many years before age-related fertility decline begins (typically after age 35), giving you ample time to address PCOS-related ovulatory issues. 4

Critical Preconception Planning

When you are ready to conceive, you should:

  • Undergo preconception metabolic screening including fasting glucose, lipid profile, blood pressure, and thyroid function to identify modifiable risk factors. 4

  • Ensure adequate folic acid supplementation (at least 400-800 mcg daily) starting 3 months before conception. 4

  • Maintain close monitoring during pregnancy, as PCOS increases risk of gestational diabetes and preeclampsia, though these are manageable with appropriate prenatal care. 4

Common Pitfalls to Avoid

  • Do not assume you are infertile simply because you have PCOS—most women with PCOS conceive successfully with or without assistance. 3

  • Do not continue spironolactone once you begin trying to conceive, as it poses teratogenic risk and offers no fertility benefit. 5, 4

  • Do not delay seeking fertility evaluation if you have not conceived after 6-12 months of timed intercourse after stopping medications, as early intervention improves outcomes. 3

  • Do not neglect lifestyle modifications—even modest weight loss (5%) significantly improves ovulation and pregnancy rates in PCOS. 4

References

Guideline

Recommended Birth Control Pill Regimen for PCOS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Combined Oral Contraceptives as First‑Line Therapy for Polycystic Ovary Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021

Guideline

Management of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Why prescribe combined oral contraceptive pills for a reproductive‑age woman with polycystic ovary syndrome who has normal weight, normal metabolic parameters, and regular menstrual cycles?
What is the preferred first‑line contraceptive for a reproductive‑age woman with polycystic ovary syndrome, including dosing, regimen, contraindications, and alternative options for symptom control?
What is the recommended approach for patients with Polycystic Ovary Syndrome (PCOS) considering intradermal contraceptives?
What is the first-line medication treatment for polycystic ovarian syndrome (PCOS)?
What is the best contraceptive for Polycystic Ovary Syndrome (PCOS)?
Should I still obtain a gamma‑glutamyl transferase (GGT) level in a patient with right‑upper‑quadrant (RUQ) pain after cholecystectomy?
What is the target mean arterial pressure (MAP) after implantation of a Brio ventricular assist device (VAD)?
What is the first‑line therapy for borderline personality disorder?
What next antihypertensive should be added for a patient on losartan 50 mg, hydrochlorothiazide 25 mg, amlodipine 10 mg, with borderline hyperkalaemia and a history of asthma/COPD?
In a middle‑aged adult with persistent ulnar‑sided wrist pain worsened by gripping and pronation, how is ulnocarpal abutment syndrome diagnosed and what is the initial conservative treatment?
Given low serum iron, low ferritin, low transferrin saturation, high‑normal total iron‑binding capacity, and a normal reticulocyte percentage, what are the next steps in evaluation and management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.